Oxford Vaccine Trials Produce Robust Immune Response In Elderly: Report.

NDTV News

NDTV.com provides latest news from India and the world. Get today’s news headlines from Business, Technology, Bollywood, Cricket, videos, photos, live news coverage and exclusive breaking news from India.

https://www.ndtv.com/

Oxford COVID-19 Vaccine Trials Produce Robust Immune Response In Elderly: Report

Oxford COVID-19 Vaccine: Oxford and AstraZeneca did not immediately respond to request for comments

The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among the elderly, British drug maker AstraZeneca Plc said on Monday.

A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.

"It is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the COVID-19 disease severity is higher," an AstraZeneca spokesman told Reuters.

"The results further build the body of evidence for the safety and immunogenicity of AZD1222," the spokesman said, referring to the technical name of the vaccine.

The news that older people get an immune response from the vaccine is positive because the immune system weakens with age and older people are those most at risk of dying from the virus.

The Financial Times reported earlier that the vaccine, being developed by Oxford and AstraZeneca, triggers protective antibodies and T-cells in older age groups - among those most at risk from the virus.

The Oxford/AstraZeneca vaccine is expected to be one of the first from big pharma to secure regulatory approval, along with Pfizer and BioNTech's candidate.

If it works, a vaccine would allow the world to return to some measure of normality after the tumult of the pandemic.

Immunogenicity blood tests carried out on a subset of older participants echo data released in July which showed the vaccine generated "robust immune responses" in a group of healthy adults aged between 18 and 55, the Financial Times reported.

Details of the finding are expected to be published shortly in a clinical journal, the FT said. It did not name the publication.

OXFORD VACCINE

British Health Secretary Matt Hancock said a vaccine was not yet ready though he was preparing logistics for a possible roll out.

Newsbeep


"I would expect the bulk of the roll out to be in the first half of next year," Hancock told the BBC.

Asked if some people could receive a vaccine this year he told the BBC: "I don't rule that out but that is not my central expectation."

"We want to be ready in case everything goes perfectly but it's not my central expectation that we'll be doing that this year, but the programme is progressing well, we're not there yet," Hancock said.

Called AZD1222 or ChAdOx1 nCoV-19, the vaccine was developed by Oxford University scientists and licensed to AstraZeneca in April, which took on the task of scaling trials and production.

The vaccine is likely to provide protection for about a year, CEO Pascal Soriot said in June.

The British drugmaker has signed several supply and manufacturing deals with companies and governments around the world as it gets closer to reporting early results of a late-stage clinical trial.

AstraZeneca resumed the U.S. trial of the experimental vaccine after approval by U.S. regulators, the company said on Friday.

Staff at a London hospital trust have been told to be ready to receive the first batches of the vaccine being developed by the University of Oxford and AstraZeneca Plc, The Sun newspaper reported on Monday.

The Sun said the hospital, which was not identified, was told to prepare for the vaccine from the "week commencing the 2 November".

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Дзеркало Тижня Пожежа на Барабашово: поліція оголосила свою версію. Дзеркало Тижня Вогонь гасили 10 годин.  
УНІАН Врахували досвід Нагірного Карабаху: ЗСУ провели унікальні навчання з використанням Bayraktar і Javelin. УНІАН Головною метою маневрів було бойове злагодження підрозділів. Окрім того, військові відпрацювали залученням новітніх систем озброєння і управління боєм.
Главком Тихановська хоче зустрітися з Путіним, бо «білоруси на це чекають». Главком Тихановську цікавить позиція Росії з білоруського питання
Цензор.НЕТ Яценюк: Захід має запровадити санкції проти депутатів пропутінської партії ОПЗЖ. Цензор.НЕТ Проти депутатів пропутінської партії ОПЗЖ, які виконують російське замовлення щодо підриву відносин України зі США та ЄС, Захід має запровадити санкції та позбавити їх права в'їзду. А СБУ зобов'язана боротися з усією російською агентурою.
Обозреватель Таке – не літає, або На городі бузина, а у Кабміні – «бізнес-ангели» ?. Обозреватель Деякі цифри зі "Стратегії" від уряду
Новини по темі

Fact check: Trump’s claims on role of U.S. military in COVID-19 vaccine plan

U.S. President Donald Trump has miscast or exaggerated the military's role in the crash program to accelerate the development, production and eventual distribution of COVID-19 vaccines.

Demonstrators plan protests across France over security bill.

Dozens of rallies are taking place against the controversial bill, which was approved by the lower house of Parliament this week but still awaits a green light from the Senate.

Britain, European Union resume face-to-face trade talks as deadline approaches.

If there is no deal, New Year's Day will bring huge disruption, with the overnight imposition of tariffs and other barriers to U.K.-EU trade.

New Method To Detect Single Virus Particles May Lead To Faster Covid Test.

Scientists have developed a new method for identifying single virus particles based on changes in electrical current when they pass through ultrasmall pores, an advance which they claim may lead to...

Ajit Doval Participates In Trilateral Maritime Meeting In Sri Lanka.

National Security Advisor Ajit Doval on Saturday took part in the high-level trilateral maritime dialogue here among India, Sri Lanka and the Maldives.

Iran’s president pins nuclear scientist death on Israel, vows revenge at ‘proper time’.

Iran's clerical and military rulers have threatened revenge for Friday's killing of Mohsen Fakhrizadeh, which could further increase tensions in the Middle East region and beyond.

Number of COVID-19 cases confirmed worldwide exceeds 61.

The overall death toll is 1,442,921 people, while 39,461,100 coronavirus patients have already recovered.

Prisoners, advocates hope Guantanamo Bay will finally close under Biden presidency.

Those pushing for its closure now see a window of opportunity, hoping Biden's administration will find a way to prosecute those who can be prosecuted and release the rest.

«Global Arrogance» : Iran Slams Israel, US After Top Scientist's Death.

Iran's President Hassan Rouhani Saturday accused arch-foe Israel of acting as a "mercenary" for the US, blaming the Jewish state for assassinating one of Tehran's prominent nuclear scientists the day...

U.S. coronavirus vaccine plans take shape as hospitalizations set new records

Political leaders have clamped down with increasingly aggressive measures to curtail the spread of the virus, which has reached unseen levels.